Cardiatec

Curing Heart Disease Through AI-Driven Molecule Discovery.

About

Pre-clinical TechBio company focused on Cardiovascular Disease. Cardiatec leverages large and high-dimensional multi-comics data to discover differentiated and translatable therapeutics to better navigate complex disease biology.

Milestones

Founded 2021
Invested 2024

Leadership

Namshik Han
Raphael Peralta
Thelma Zablocki

“LQD is a fund with engaged, hands-on partners from whom we derive direct value and support.”
Thelma Zablocki COO and Founder

Cardiatec at a glance.

CardiaTec Raises €5.8 Million ($6.5M) Seed Funding for Computational Cardiovascular Drug Discovery Platform.

September 2024

CardiaTec Secures £1.4 Million Pre-Seed Investment Led by Laidlaw.

July 2022

Next company